These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26099922)

  • 1. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.
    Assis PA; De Figueiredo-Pontes LL; Lima AS; Leão V; Cândido LA; Pintão CT; Garcia AB; Saggioro FP; Panepucci RA; Chahud F; Nagler A; Falcão RP; Rego EM
    J Exp Clin Cancer Res; 2015 Jun; 34(1):65. PubMed ID: 26099922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.
    de Figueiredo-Pontes LL; Assis PA; Santana-Lemos BA; Jácomo RH; Lima AS; Garcia AB; Thomé CH; Araújo AG; Panepucci RA; Zago MA; Nagler A; Falcão RP; Rego EM
    PLoS One; 2011; 6(10):e26713. PubMed ID: 22053203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
    Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism.
    Yee KO; Connolly CM; Pines M; Lawler J
    Cancer Biol Ther; 2006 Feb; 5(2):218-24. PubMed ID: 16418571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
    Mirzoeva S; Franzen CA; Pelling JC
    Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of vascular endothelial growth factor-C on the cell growth and angiogenesis in NB4 cell xenograft tumor].
    Ding KY; Bai X; Ruan CG; Dai L; Dong NZ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):94-8. PubMed ID: 21429374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study.
    Abramovitch R; Itzik A; Harel H; Nagler A; Vlodavsky I; Siegal T
    Neoplasia; 2004; 6(5):480-9. PubMed ID: 15548356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
    Sato S; Kawamura H; Takemoto M; Maezawa Y; Fujimoto M; Shimoyama T; Koshizaka M; Tsurutani Y; Watanabe A; Ueda S; Halevi K; Saito Y; Yokote K
    Biochem Biophys Res Commun; 2009 Feb; 379(2):411-6. PubMed ID: 19114027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
    Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
    Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.
    Leiba M; Cahalon L; Shimoni A; Lider O; Zanin-Zhorov A; Hecht I; Sela U; Vlodavsky I; Nagler A
    J Leukoc Biol; 2006 Aug; 80(2):399-406. PubMed ID: 16769768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.
    Ferreira AK; Santana-Lemos BA; Rego EM; Filho OM; Chierice GO; Maria DA
    Br J Cancer; 2013 Nov; 109(11):2819-28. PubMed ID: 24201752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine acute promyelocytic leukemia cells can be recognized and cleared in vivo by adaptive immune mechanisms.
    Pollock JL; Lane AA; Schrimpf K; Ley TJ
    Haematologica; 2005 Aug; 90(8):1042-9. PubMed ID: 16079103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.
    Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H
    Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
    Zhu Z; Hattori K; Zhang H; Jimenez X; Ludwig DL; Dias S; Kussie P; Koo H; Kim HJ; Lu D; Liu M; Tejada R; Friedrich M; Bohlen P; Witte L; Rafii S
    Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.
    Zorzoli A; Di Carlo E; Cocco C; Ognio E; Ribatti D; Ferretti E; Dufour C; Locatelli F; Montagna D; Airoldi I
    Clin Cancer Res; 2012 Mar; 18(6):1630-40. PubMed ID: 22383738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.